Published On: 4/3/2019
2019 Women in Business Award!
We would like to congratulate Meg Powell, our Co-Founder and current Board Chair, on her recognition by the Triangle Business Journal. Read more: http://bizj.us/1pubqj
About Target RWE
Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables comprehensive insight generation from complete retrospective and prospective longitudinal patient journeys, with unparalleled scale and accuracy.
Visit our website to learn more: https://targetrwe.com/
Contact:
Kayla Slake
Senior Manager, Marketing
984.234.0268 ext 205
More News
-
05/09/2025
Target RWE at EASL 2025: Advancing HCC, MASH & PBC Research -
05/08/2025
EASL 2025 Research: Presentation by Michael Roden, MD -
04/25/2025
How does causalStudio™ address the key regulatory requirements for data integrity, traceability, and analysis? -
04/03/2025
An Overview of MASH: Advancements in Diagnosis, Treatment, and the Role of Real-World Data -
03/31/2025
Addressing the Burden of Hidradenitis Suppurativa: The Often-Hidden Impact on Quality of Life